Presidential Science Aide Got Funding from Hwang
By Chosun Ilbo,
Chosun Ilbo
| 01. 17. 2006
The presidential advisor for science and technology Park Ky-young admitted Tuesday to a conflict of interest arising from W250 million (US$250,000) in research grants she received from the disgraced cloning scientist Hwang Woo-suk. Hwangîs motives have come under suspicion because although Park received the money when she was still a botanist at Sunchon National University in South Jeolla Province and before taking the Cheong Wa Dae post in 2004, she already had the presidentîs ear at the time. She insists the funding was spent in a transparent manner.
"I accepted W150 million from Hwang, who was in charge of producing a BSE-resistant cow in December 2001, when I was working as a botany professor at Sunchon National University, to carry out research projectsñ on social implications and research ethics, she said.
She said Hwang gave her another W100 million in June 2003, asking her to study the ethical and industrial impact of bio-organs, as part of a project on producing bio-organs by using transgenic cloning technology and developing transplant technology. Park was appointed presidential aide the following year.
The official...
Related Articles
By staff, Japan Times | 12.04.2025
Japan plans to introduce a ban with penalties on implanting a genome-edited fertilized human egg into the womb of a human or another animal amid concerns over "designer babies."
A government expert panel broadly approved a proposal, including the ban...
By David Jensen, The California Stem Cell Report | 12.11.2025
California’s stem cell and gene therapy agency today approved spending $207 million more on training and education, sidestepping the possibility of using the cash to directly support revolutionary research that has been slashed and endangered by the Trump administration.
Directors...
By Carter Sherman, The Guardian | 12.08.2025
A huge defense policy bill, revealed by US lawmakers on Sunday, does not include a provision that would have provided broad healthcare coverage for in vitro fertilization (IVF) for active-duty members of the military, despite Donald Trump’s pledge...
By Frankie Fattorini, Pharmaceutical Technology | 12.02.2025
Próspera, a charter city on Roatán island in Honduras, hosts two biotechs working to combat ageing through gene therapy, as the organisation behind the city advertises its “flexible” regulatory jurisdiction to attract more developers.
In 2021, Minicircle set up a...